Long-Acting GHRH Analog (DAC-Modified)

CJC-1295 with DAC (10mg) is supplied in Australia by Daza Enhanced with fast domestic shipping to all states and territories.

CJC-1295 with DAC is a stabilised GHRH analog modified with a Drug Affinity Complex (DAC) that covalently binds to plasma albumin, extending its biological half-life to 6–8 days. This contrasts with non-DAC GHRH analogs (Mod GRF 1-29), which have ~30 minute activity. Sustained activity is studied for prolonged GH and IGF-1 elevation from a single administration.

Research interest centres on the downstream effects of sustained GH/IGF-1 elevation: lean mass research, fat metabolism, tissue repair, and sleep architecture.

Key Research Areas

• Sustained GH/IGF-1 Elevation — Single-dose activity window of 6–8 days — longest in the GHRH analog class
• Body Composition — GH-driven IGF-1 production studied for protein synthesis and lean mass research
• Fat Mobilisation — GH-mediated lipolysis studied for visceral adipose tissue research
• Tissue Repair — Sustained GH elevation studied across muscle and connective tissue models
• Sleep Research — Elevated GH levels studied in connection with sleep architecture

Supplied as lyophilized powder at ≥99% purity, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.